REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 560.78 Mn 2032 | 12.57% | North American |
By Type | By Origin | By Cosmetic Application |
---|---|---|
|
|
|
SCOPE OF THE REPORT
PRP and PRF in the Cosmetics Market Overview
The PRP and PRF in the Cosmetics Market Size is estimated to be worth USD 215.51 million in 2023 and is forecasted to grow to USD 560.78 million by 2032, with a compound annual growth rate (CAGR) of 12.57% during the forecast period spanning from 2024 to 2032.
The utilization of PRP and PRF for skin treatment is on the rise. PRP therapy is utilized in cosmetic procedures to reduce acne scars, enhance skin tone, diminish deep wrinkles, and tighten sagging skin. The older and middle-aged demographic are opting for plastic surgery more frequently to maintain a youthful appearance. Consequently, it is expected that the market will expand in the coming years as more individuals become informed about these procedures. Recently, both small and large biopharmaceutical companies have increasingly turned to contract research organizations (CROs) and other clinical service providers to support their research and development activities.
The growth of PRP and PRF in the cosmetics industry worldwide is shaped by shifts in lifestyle trends in developing countries, higher disposable incomes, and a growing emphasis on personal care. Furthermore, the market is expected to see a boost from the outsourcing of stem cell research by the conclusion of the projected timeframe. In numerous emerging markets, the demand for PRP and PRF in cosmetics has been primarily fueled by the increasing interest of the younger population in grooming practices.
Businesses are contemplating expanding their capacity to meet the growing demand for different cosmetic applications, including PRF for facial rejuvenation. The demand for PRP & PRF facial therapy is expected to surge during the forecasted period. Following the peak of the COVID-19 pandemic, consumers’ buying power has risen, prompting companies to capitalize on this opportunity by increasing awareness of the benefits of PRP and PRF in clinics and encouraging their utilization.
The Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) market in cosmetics is rapidly expanding due to the rising demand for natural, non-surgical rejuvenation treatments. These therapies harness the patient’s own blood components to promote skin healing, collagen production, and overall rejuvenation, resulting in benefits such as improved skin texture, reduced wrinkles, and enhanced skin tone. The popularity of these treatments is increasing because of their minimally invasive nature, lower risk of adverse reactions, and effectiveness in addressing various cosmetic concerns. Market growth is also driven by technological advancements and improved techniques, making PRP and PRF procedures more accessible and cost-effective. Clinics and med spas are incorporating these treatments into their services, often combining them with other procedures like micro needling and laser therapy for better outcomes. As consumer awareness and acceptance of regenerative medicine in cosmetics continues to rise, the PRP and PRF market is set for continuous innovation and expansion.
ATTRIBUTE | Specifications |
Market Size Value In 2023 | USD 215.51 Million |
Revenue Forecast In 2032 | USD 560.78 Million |
Growth Rate CAGR | CAGR of % from 2024 to 2032 |
Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2024 to 2032 |
Historic Year | 2019 to 2023 |
Forecast Year | 2024-2032 |
By Product |
|
By Application |
|
Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Competitive Landscape | Stryker Corporation, Croma-Pharma GmbH, Eclipse Aesthetics, Zimmer Biomet, Isto Biologics, Estar Medical, Exactech, Inc., EmCyte Corporation, Regen Lab SA, Arthrex, Inc., APEX Biologix, ThermoGenesis Holdings, Inc. |
Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Segmentation Analysis
The Cosmetics market segments PRP and PRF based on type, origin, and cosmetic application. The market is divided into Pure-PRP, Leukocyte-rich PRP, and Pure-PRF based on type. Origin-wise, PRP and PRF in Cosmetics are categorized as Autologous, Allogeneic, Homologous, and Others. In terms of cosmetic application, PRP and PRF in Cosmetics are classified into Skin Rejuvenation, Face Lift, Hair Application, Plastic Surgery, Scar-related Treatment, and Others.
The Pure-PRP category plays a crucial role in the cosmetics market by being a major contributor to both PRP and PRF.
According to the classification, the market is divided into Pure-PRP, Leukocyte-rich PRP, and Pure-PRF. The dominant category in the market is Pure-PRP. Pure PRP contains high concentrations of platelets and growth factors, which are beneficial for skin rejuvenation. As a result, there is a growing demand for Pure PRP. In the coming years, it is expected that technological advancements will drive the industry by facilitating the use of Pure PRP in various applications and platelet-rich plasma. Moreover, it is predicted that the industry will soon be influenced by cost-effectiveness and ease of production. Leukocyte-rich PRP is used for purposes such as enhancing bone regeneration, repairing soft tissues, and promoting wound healing.
The Oncology sector experienced rapid growth.
According to the cosmetic application, PRP and PRF in Cosmetics are categorized into Skin Rejuvenation, Face Lift, Hair Application, Plastic Surgery, Scar-related Treatment, and Others. The market is mainly led by the skin rejuvenation segment. The growing popularity of PRP therapies in cosmetic facial procedures and the increasing number of cosmetic surgeries are driving the demand for PRP and PRF cosmetic treatments, particularly for skin rejuvenation. The global demand for PRP therapies is on the rise due to the growing need for skin rejuvenation treatments.
Competitive Landscape
The cosmetics industry’s PRP and PRF market is highly competitive, as numerous companies strive for innovation and increased effectiveness in their treatments. Leading companies such as Regen Lab SA, Eclipse Aesthetics, Estar Medical, and Arthrex, Inc. are heavily investing in research and development to improve their products and broaden their market reach. Strategic partnerships, collaborations, and mergers and acquisitions are frequently utilized to gain a competitive advantage. Moreover, these companies are prioritizing the training and education of practitioners to guarantee the safe and efficient administration of PRP and PRF treatments.
Some Major Key Players in The PRP And PRF In the Cosmetics Market:
- Stryker Corporation,
- Croma-Pharma GmbH,
- Eclipse Aesthetics
- Zimmer Biomet,
- Isto Biologics,
- Estar Medical
- Exactech, Inc.,
- EmCyte Corporation,
- Regen Lab SA,
- Arthrex, Inc.
- APEX Biologix
- ThermoGenesis Holdings, Inc.
Recent Developments
- ALBANY, N.Y., June 3, 2022 – The PRP and PRF in cosmetics market is estimated to cross a valuation of US$ 150 Mn by 2031. Substantial rise in spending for skin rejuvenation therapies is creating opportunities in PRF and PRP in cosmetics market. Increasing economic prosperity and growing awareness for personal grooming among individuals of all age groups stokes demand for PRF and PRP in cosmetics procedures in emerging economies.
- In 2021, Zimmer Biomet Holdings Inc., a leader in musculoskeletal healthcare, established a strategic agreement with OSSIS, a hip replacement treatment firm based in New Zealand. The cooperation sought to promote Zimmer Biomet’s patient-specific 3D-printed titanium hip replacement joints in Asia Pacific. The agreement is expected to enhance Zimmer Biomet’s product line of hip replacement options and supporting technologies.
Regional Analysis
The North American market for PRP and PRF in the cosmetics industry commands a substantial portion of regional revenue.
The North American PRP and PRF segments in the cosmetics industry are forecasted to capture the largest market share in terms of revenue in the coming years. This upward trajectory is expected to persist throughout the forecast period, fueled by the introduction of new products, technological innovations, and a surge in the utilization of PRP in cosmetic procedures within the region. Anticipated growth in government healthcare expenditure and advancements in PRP & PRF applications in cosmetics are poised to propel the North American market forward over the forecasted timeframe.
Moreover, Europe is anticipated to witness growth in the global PRP and PRF segments within the cosmetics industry. The demand for PRP & PRF in the European cosmetics market is being bolstered by cosmetic procedures and a rise in aesthetic surgeries in the region. The well-established healthcare infrastructure in Europe, the increasing popularity of platelet-rich plasma for hair treatments, the uptick in both general and cosmetic surgical procedures, and the utilization of injectable PRF for facial rejuvenation collectively indicate an expansion in the market within the region.
Market Dynamics
Trends
The cosmetic industry is experiencing a shift towards combination therapies in the PRP and PRF market, with these treatments being utilized in conjunction with procedures like micro needling and laser therapy for improved outcomes. The market is being influenced by the growing popularity of personalized medicine and customized cosmetic treatments. Moreover, there is a rising interest in natural and holistic beauty solutions, leading to a higher demand for PRP and PRF treatments.
Opportunities
The PRP and PRF market holds promising growth prospects, especially in developing markets witnessing an increase in consumer awareness and disposable incomes. The introduction of affordable and easy-to-use PRP and PRF kits opens up avenues for expanding the market. Collaborations with cosmetic clinics and dermatologists can further boost the exposure and acceptance of PRP and PRF treatments. The rise in medical tourism and the surge in demand for non-invasive cosmetic procedures further contribute to the potential for market expansion.
Challenges
Significant obstacles in the PRP and PRF market involve guaranteeing treatment consistency and quality, maneuvering through intricate regulatory environments, and tackling the expensive nature of treatments. The requirement for ongoing innovation and research to validate the advantages and safety of PRP and PRF treatments can also pose a challenge. Moreover, the presence of competition from well-established cosmetic treatments and procedures may affect market expansion.
Segments Covered in the PRP and PRF in the Cosmetics Market Report
By Type
- Pure-PRP
- Leukocyte-rich PRP
- Pure-PRF
By Origin
- Autologous
- Allogeneic
- Homologous
- Others
By Cosmetic Application
- Skin Rejuvenation
- Face Lift
- Hair Application
- Plastic Surgery
- Scar-related Treatment
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
FAQ
PRP (Platelet-Rich Plasma) and PRF (Platelet-Rich Fibrin) treatments involve extracting platelets and fibrin from the patient’s own blood and injecting them into the skin to stimulate collagen production and enhance skin regeneration.
The PRP and PRF in the Cosmetics Market Size is valued at USD 215.51 million in 2023 and is predicted to reach USD 560.78 million by the year 2032.
The PRP and PRF in the Cosmetics Market is expected to grow at a 12.57 % CAGR during the forecast period for 2024-2032.
Estar Medical, Exactech, Inc., EmCyte Corporation, Regen Lab SA, Arthrex, Inc., APEX Biologix, ThermoGenesis Holdings, Inc.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.